Impact of COVID-19 on patients awaiting ablation for atrial fibrillation.
COVID-19
atrial fibrillation
catheter ablation
delivery of health care
Journal
Open heart
ISSN: 2053-3624
Titre abrégé: Open Heart
Pays: England
ID NLM: 101631219
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
10
01
2022
accepted:
11
04
2022
entrez:
13
6
2022
pubmed:
14
6
2022
medline:
16
6
2022
Statut:
ppublish
Résumé
Atrial fibrillation (AF) ablation services were significantly affected by the COVID-19 pandemic. We aimed to evaluate a symptom-based clinician prioritisation scheme for waiting list management compared with patient-completed quality of life (QoL) scores. We also sought to understand factors influencing QoL, particularly the impact of COVID-19, on patients awaiting AF ablation, via a bespoke questionnaire. Patients awaiting AF ablation were sent two QoL questionnaires (Atrial Fibrillation Effect on QualiTy of Life (AFEQT) and EuroQol 5D (EQ5D-5L)) and the bespoke questionnaire. At a separate time point, patients were categorised as C1-urgent, C2-priority or C3-routine by their cardiologist based on review of clinic letters. There were 118 patients included with priority categorisation available for 86 patients. Median AFEQT scores were lower in C2 (30.4; 17.2-51.9) vs C3 patients (56.5; 32.1-74.1; p<0.01). Unplanned admission occurred in 3 patients in C3 with AFEQT scores of <40. Although 65 patients had AF symptoms during the pandemic, 43.1% did not seek help where they ordinarily would have. An exercise frequency of ≥3-4 times a week was associated with higher AFEQT (56.5; 41.2-74.1; p<0.001) and EQ5D (0.84; 0.74-0.88; p<0.0001) scores. The QoL of patients awaiting AF ablation is impaired and AFEQT helps to identify patients at risk of admission, over and above physician assessment. COVID-19 influenced patients seeking medical attention with symptomatic AF when they normally would. Regular exercise is associated with better QoL in patients awaiting AF ablation.
Identifiants
pubmed: 35697474
pii: openhrt-2022-001969
doi: 10.1136/openhrt-2022-001969
pmc: PMC9195158
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Curr Cardiol Rep. 2020 Aug 8;22(10):111
pubmed: 32770492
J Am Coll Cardiol. 2017 Oct 17;70(16):2022-2035
pubmed: 29025560
J Am Coll Cardiol. 2013 Mar 19;61(11):1177-82
pubmed: 23375926
JAMA. 2019 Apr 2;321(13):1275-1285
pubmed: 30874716
Circulation. 2012 Jun 12;125(23):2933-43
pubmed: 22689930
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
J Cardiopulm Rehabil Prev. 2019 Mar;39(2):65-72
pubmed: 30801433
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):15-25
pubmed: 21160035
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3166-3175
pubmed: 33022815
Europace. 2020 Dec 23;22(12):1841-1847
pubmed: 32995866
JACC Clin Electrophysiol. 2019 Mar;5(3):330-339
pubmed: 30898236
JAMA. 2019 Apr 2;321(13):1261-1274
pubmed: 30874766
Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):393-402
pubmed: 26058720
J Rehabil Med. 2019 Jun 18;51(6):442-450
pubmed: 30931484
Eur Heart J Qual Care Clin Outcomes. 2021 May 3;7(3):247-256
pubmed: 33079204
Am Heart J. 2014 May;167(5):735-42.e2
pubmed: 24766985